Literature DB >> 16412380

Role of c-Src and focal adhesion kinase in progression and metastasis of estrogen receptor-positive breast cancer.

Maricarmen D Planas-Silva1, Richard D Bruggeman, Ronald T Grenko, J Stanley Smith.   

Abstract

The non-receptor tyrosine kinases c-Src and focal adhesion kinase (Fak) mediate signal transduction pathways that regulate cell proliferation, survival, invasion, and metastasis. Here, we investigated whether c-Src and Fak are activated during progression of hormone-dependent breast cancer. Maximally active c-Src was overexpressed in a subset of tamoxifen-resistant variants and in metastases of recurrent hormone-treated breast cancer. Active Fak was also frequently observed in these tumors. We also show that estrogen receptor (ER) can bind to Fak and that estrogen can modulate Fak autophosphorylation supporting a cross-talk between these two pathways. Inhibition of c-Src activity blocked proliferation of all tamoxifen-resistant variants, suggesting that inhibitors of c-Src-Fak activity may delay or prevent progression and metastasis of ER-positive tumors. These studies also raise the possibility that fully active forms of c-Src and Fak in breast tumors may be biomarkers to predict tamoxifen resistance and/or risk of recurrence in ER-positive breast cancer.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16412380     DOI: 10.1016/j.bbrc.2005.12.164

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  36 in total

1.  PTPL1/PTPN13 regulates breast cancer cell aggressiveness through direct inactivation of Src kinase.

Authors:  Murielle Glondu-Lassis; Mathilde Dromard; Magali Lacroix-Triki; Philippe Nirdé; Carole Puech; Dora Knani; Dany Chalbos; Gilles Freiss
Journal:  Cancer Res       Date:  2010-05-25       Impact factor: 12.701

2.  Focal adhesion kinase mediates TGF-beta1-induced renal tubular epithelial-to-mesenchymal transition in vitro.

Authors:  Bingqing Deng; Xiao Yang; Jianshe Liu; Fangfang He; Zhonghua Zhu; Chun Zhang
Journal:  Mol Cell Biochem       Date:  2010-02-23       Impact factor: 3.396

3.  Luminal breast cancer metastasis is dependent on estrogen signaling.

Authors:  Vidya Ganapathy; Whitney Banach-Petrosky; Wen Xie; Aparna Kareddula; Hilde Nienhuis; Gregory Miles; Michael Reiss
Journal:  Clin Exp Metastasis       Date:  2012-03-17       Impact factor: 5.150

4.  Expression of FAK-related non-kinase (FRNK) coincides with morphological change in the early stage of cell adhesion.

Authors:  Yuuki Nagoshi; Gou Yamamoto; Tarou Irie; Tetsuhiko Tachikawa
Journal:  Med Mol Morphol       Date:  2006-09       Impact factor: 2.309

5.  Shorter disease-specific survival of ER-positive breast cancer patients with high cytoplasmic Src kinase expression after tamoxifen treatment.

Authors:  B Elsberger; D M Paravasthu; S M Tovey; J Edwards
Journal:  J Cancer Res Clin Oncol       Date:  2011-12-02       Impact factor: 4.553

6.  Estrogen receptor-alpha promotes breast cancer cell motility and invasion via focal adhesion kinase and N-WASP.

Authors:  Angel Matias Sanchez; Marina Ines Flamini; Chiara Baldacci; Lorenzo Goglia; Andrea Riccardo Genazzani; Tommaso Simoncini
Journal:  Mol Endocrinol       Date:  2010-09-29

7.  Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530.

Authors:  Y-M Chang; L Bai; S Liu; J C Yang; H-J Kung; C P Evans
Journal:  Oncogene       Date:  2008-08-04       Impact factor: 9.867

8.  The dual kinase complex FAK-Src as a promising therapeutic target in cancer.

Authors:  Victoria Bolós; Joan Manuel Gasent; Sara López-Tarruella; Enrique Grande
Journal:  Onco Targets Ther       Date:  2010-06-24       Impact factor: 4.147

9.  Inhibition of focal adhesion kinase and src increases detachment and apoptosis in human neuroblastoma cell lines.

Authors:  Elizabeth A Beierle; Xiaojie Ma; Angelica Trujillo; Elena V Kurenova; William G Cance; Vita M Golubovskaya
Journal:  Mol Carcinog       Date:  2010-03       Impact factor: 4.784

10.  Phosphoproteomic Analysis Identifies Focal Adhesion Kinase 2 (FAK2) as a Potential Therapeutic Target for Tamoxifen Resistance in Breast Cancer.

Authors:  Xinyan Wu; Muhammad Saddiq Zahari; Santosh Renuse; Raja Sekhar Nirujogi; Min-Sik Kim; Srikanth S Manda; Vered Stearns; Edward Gabrielson; Saraswati Sukumar; Akhilesh Pandey
Journal:  Mol Cell Proteomics       Date:  2015-09-01       Impact factor: 5.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.